A prospective biomarker analysis of alvocidib followed by cytarabine and mitoxantrone in MCL-1-dependent relapsed/refractory acute myeloid leukemia

  1. Zeidner, J.F.
  2. Lin, T.L.
  3. Vigil, C.E.
  4. Fine, G.
  5. Yair Levy, M.
  6. Nazha, A.
  7. Esteve, J.
  8. Lee, D.J.
  9. Yee, K.
  10. Dalovisio, A.
  11. Wang, E.S.
  12. Bergua Burgues, J.M.
  13. Schriber, J.
  14. Litzow, M.R.
  15. Frankfurt, O.
  16. Castillo, T.B.D.
  17. Bhatt, V.R.
  18. Bhatnagar, B.
  19. Mehta, P.
  20. Dillon, R.
  21. Vicente, M.V.
  22. Anthony, S.
  23. Bearss, D.
  24. Montesinos, P.
  25. Douglas Smith, B.
Journal:
Blood Cancer Journal

ISSN: 2044-5385

Year of publication: 2021

Volume: 11

Issue: 10

Type: Letter

DOI: 10.1038/S41408-021-00568-3 GOOGLE SCHOLAR lock_openOpen access editor
Data source: Scopus